mRNA expression of neuronatin (NNAT) has been reported in pituitary adenoma, prostatic cancer with neuroendocrine features, large cell neuroendocrine carcinoma lung and thyroid stimulating hormone-producing tumors in mice. This evidence concerns the gene NNAT and prostate carcinoma.